These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 23887074)

  • 61. Low-dose hCG supplementation after GnRH agonist triggering: Don't be too quick on the trigger.
    Bodri D
    Hum Reprod; 2013 Sep; 28(9):2315-7. PubMed ID: 23633554
    [No Abstract]   [Full Text] [Related]  

  • 62. Risk factors for ovarian hyperstimulation syndrome: relevance of the number of follicles, serum estradiol levels and the number of oocytes collected.
    Ata B; Seyhan A; Polat M; Young Son W; Yarali H; Dahan M
    Hum Reprod; 2013 Sep; 28(9):2595. PubMed ID: 23838158
    [No Abstract]   [Full Text] [Related]  

  • 63. Gonadotropin-releasing hormone agonist to induce final oocyte maturation prevents the development of ovarian hyperstimulation syndrome in high-risk patients and leads to improved clinical outcomes compared with coasting.
    DiLuigi AJ; Engmann L; Schmidt DW; Maier DB; Nulsen JC; Benadiva CA
    Fertil Steril; 2010 Aug; 94(3):1111-4. PubMed ID: 20074722
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Gonadotropin-releasing hormone agonist combined with a reduced dose of human chorionic gonadotropin for final oocyte maturation in fresh autologous cycles of in vitro fertilization.
    Shapiro BS; Daneshmand ST; Garner FC; Aguirre M; Thomas S
    Fertil Steril; 2008 Jul; 90(1):231-3. PubMed ID: 17981269
    [TBL] [Abstract][Full Text] [Related]  

  • 65. GnRHa to trigger final oocyte maturation: a time to reconsider.
    Humaidan P; Papanikolaou EG; Tarlatzis BC
    Hum Reprod; 2009 Oct; 24(10):2389-94. PubMed ID: 19608565
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [In vitro oocyte maturation for safer treatment of infertility. The risk of ovarian overstimulation syndrome is minimized].
    Hreinsson J; Fridström M
    Lakartidningen; 2004 Nov; 101(46):3665-8, 3671. PubMed ID: 15586490
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Ovarian hyperstimulation syndrome prevention strategies: use of gonadotropin-releasing hormone antagonists.
    Griesinger G
    Semin Reprod Med; 2010 Nov; 28(6):493-9. PubMed ID: 21082508
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Ovarian hyperstimulation syndrome prevention strategies: Luteal support strategies to optimize pregnancy success in cycles with gonadotropin-releasing hormone agonist ovulatory trigger.
    Engmann L; Benadiva C
    Semin Reprod Med; 2010 Nov; 28(6):506-12. PubMed ID: 21082510
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Analogues agonists and antagonists: what is their role outside of fertilization in vitro?].
    Antoine JM; Merviel P; Alvarez S; Mandelbaum J; Salat-Baroux J; Uzan S
    Gynecol Obstet Fertil; 2000 Oct; 28(10):757-9. PubMed ID: 11244639
    [No Abstract]   [Full Text] [Related]  

  • 70. Gonadotropin-releasing hormone agonist trigger: the way to eliminate ovarian hyperstimulation syndrome--a 20-year experience.
    Kol S; Itskovitz-Eldor J
    Semin Reprod Med; 2010 Nov; 28(6):500-5. PubMed ID: 21082509
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Turn, turn, turn.
    Evers JL
    Hum Reprod; 2013 Sep; 28(9):2313-4. PubMed ID: 23887074
    [No Abstract]   [Full Text] [Related]  

  • 72. Mild/minimal stimulation for in vitro fertilization: an old idea that needs to be revisited.
    Zarek SM; Muasher SJ
    Fertil Steril; 2011 Jun; 95(8):2449-55. PubMed ID: 21550037
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Outcomes from ovarian hyperstimulation following the sole administration of gonadotrophin-releasing hormone agonist in the context of in vitro fertilization: report of two cases and review of the literature.
    Pinto E; Pinelo S; Osório M; Ferreira C; Serra H; Pires I; Barbosa A; Figueiredo H; Felgueira E; Tavares A
    Gynecol Endocrinol; 2012 Jul; 28(7):545-8. PubMed ID: 22439899
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Effects of gonadotropin-releasing hormone agonists and antagonists on luteal function.
    DiLuigi AJ; Nulsen JC
    Curr Opin Obstet Gynecol; 2007 Jun; 19(3):258-65. PubMed ID: 17495643
    [TBL] [Abstract][Full Text] [Related]  

  • 75.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 4.